SEEL Seelos Therapeutics Inc

Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that they will webcast their presentation at the 39th Annual Cowen Health Care Conference. Chairman, Founder, and CEO Raj Mehra, PhD will present on Wednesday March 13th at 10:00am ET.

The live audio webcast of the presentation can be accessed at: http://wsw.com/webcast/cowen52/seel/  

Please note that this replay will be available for 30 days following the presentation.

Seelos also announced today that they would participate in the 31st Annual ROTH Conference scheduled for March 17-19, 2019 at The Ritz Carlton, Laguna Niguel in Orange County, CA. Dr. Mehra will engaged in a moderated conversation on Tuesday, March 19th beginning at 12:30pm PT in Salon 3.

About Seelos Therapeutics:

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.

For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Contact Information:Anthony MarcianoHead of Corporate CommunicationsSeelos Therapeutics, Inc.anthony.marciano@seelostx.comwww.seelostherapeutics.com